Latest news, announcements, and milestones from NovaGenAI
NovaGenAI Sdn. Bhd. has been accepted into the NVIDIA Inception Program, gaining access to cutting-edge GPU infrastructure, technical support, and go-to-market assistance. This partnership accelerates our computational biotech and enterprise AI capabilities, particularly in AI-driven drug discovery and in-silico cellular modelling.
CryoCord Group, Malaysia's largest stem cell and cord blood banking company, deployed NovaGenAI's multilingual voice agent "James" across customer service operations. Within 90 days, the system achieved 85% call deflection, 24/7 availability in English, Bahasa Malaysia, and Mandarin, and a 40% reduction in customer service costs while maintaining 4.8/5 customer satisfaction scores.
NovaGenAI announced regional expansion with operations now active in Melbourne, Australia and Singapore. The company maintains its headquarters in Cyberjaya, Malaysia at the Bio-X Centre innovation hub. This multi-market presence enables closer collaboration with enterprise clients across the Asia-Pacific region.
NovaGenAI unveiled Clarify, an AI-native customer relationship management platform built for enterprise sales teams. Clarify combines document intelligence, automated lead enrichment, voice transcription, and predictive pipeline analytics — all powered by custom-trained language models. Early adopters report 60% reduction in manual data entry and 35% improvement in forecast accuracy.
NovaGenAI Founder and CEO Don Calaki presented "Voice AI and Document Intelligence in Healthcare Operations" at the AI in Healthcare Summit in Kuala Lumpur. The session explored real-world deployments of conversational AI in medical tourism, patient support, and clinical documentation.
NovaGenAI Sdn. Bhd. officially incorporated in Malaysia as an enterprise AI solutions provider focused on autonomous agents, voice AI, computational biotech, and custom AI systems. Headquartered at Bio-X Centre in Cyberjaya, the company brings together expertise in LLM engineering, bioinformatics, and production AI deployment.
For interviews, press materials, or partnership opportunities
Contact Press Team